Kazia Therapeutics (KZIA) Tax Provisions (2009 - 2011)

Kazia Therapeutics has reported Tax Provisions for 3 years, with the latest figure at -$6066.3 in Q4 2011.

• For the quarter ending Q4 2011, Tax Provisions rose 38.58% year-over-year to -$6066.3; the trailing twelve-month figure through Dec 2011 stood at $2.4 million (changed 0.29% YoY), and the FY2025 full-year result was -$1.1 million, down 526.11% from the prior year.
• Tax Provisions for Q4 2011 stood at -$6066.3, up from -$9876.1 in the prior quarter.
• The five-year high for Tax Provisions was -$908.95 in Q4 2009, with the low at -$9876.1 in Q4 2010.
• Historically, Tax Provisions has averaged -$5617.1 across 3 years, with a median of -$6066.3 in 2011.
• Annual changes were most pronounced in 2010 — Tax Provisions sank 986.53% — and 2011, when it soared 38.58%.
• Kazia Therapeutics' Tax Provisions stood at -$908.95 in 2009, then slumped by 986.53% to -$9876.1 in 2010, then soared by 38.58% to -$6066.3 in 2011.
• The last three Tax Provisions figures came in at -$6066.3 (Q4 2011), -$9876.1 (Q4 2010), and -$908.95 (Q4 2009), per Business Quant data.